After a near absence of IPOs for two years, the biotech industry is dipping its toe into the public markets again. So far this year, 12 biotech companies have launched IPOs. In comparison only three IPOs were filed by biotech companies in 2009 and just one in 2008. One industry watcher called this year's dozen "a miracle" and predicted the number of biotech companies going public next year could hit 25.
A Dim View of Betting on Start-Ups
Sean Parker, the entrepreneur behind Napster and Facebook now turned investor, talks about the state of the venture capital industry. He's come to a depressing conclusion about the money industry that he says used to be the engine of innovation for this country. The risk-reward doesn't work out in favor of putting money into venture capital anymore, he said, even though he himself is a partner in a VC firm that owns stakes in Facebook and SpaceX.
- Published: 21 December 2010
- Written by Investor Ideas